Literature DB >> 2040198

The safety of epoetin-alpha: results of clinical trials in the United States.

J W Eschbach1, J C Egrie, M R Downing, J K Browne, J W Adamson.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2040198     DOI： 10.1159/000419517

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  5 in total

1.  General practitioner prescribing of erythropoietin.

Authors:  S P Gibson; J B Hawkins; E S Nyholm
Journal:  BMJ       Date:  1991-10-26

Review 2.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 3.  Erythropoietin: a review.

Authors:  D M Ridley; F Dawkins; E Perlin
Journal:  J Natl Med Assoc       Date:  1994-02       Impact factor: 1.798

Review 4.  Preoperative erythropoietin in spine surgery.

Authors:  Maria J Colomina; Juan Bagó; Ferran Pellisé; Carmen Godet; Carlos Villanueva
Journal:  Eur Spine J       Date:  2004-06-09       Impact factor: 3.134

Review 5.  Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.